References
- Nadel J A. Inflammation in asthma. J Allergy Clin Immunol 1984; 73: 651–653
- Johnston S L, Holgate S T. Cellular and chemical mediators–their roles in allergic disease. Curr Opin Immunol 1990; 2: 513–524
- Le J, Vilcek J. Tumor necrosis factor and interleukin 1: Cytokines with multiple overlapping biological activities. Lab Invest 1987; 56: 234–248
- Burchett S K, Weaver W M, Westall J A, Larsen A, Kronheim S, Wilson C B. Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. J Immunol 1988; 140: 3473–3481
- Enk C, Mosbech H. Interleukin-1 production by monocytes from patients with allergic asthma after stimulation in vitro with lipopolysaccharide and Dermatophagoid pteronyssinus mite allergen. Int Arch Allergy Appl Immunol 1984; 85: 308–311
- Cavaillon J M, Dandeu J P, Mecheri S, David B. Presence of IL-1 activity in the supernatant of human monocytes challenged with purified allergenic constituents. Int Arch Allergy Appl Immunol 1984; 75: 113–119
- Hsieh K H, Lue K H, Chiang C F. Immunological changes after hyposensitization in house dust-sensitive asthmatic children: A review. J Asthma 1987; 24: 19–27
- Tamir R, Castracan J M, Rocklin R E. Generation of suppressor cells in atopic patients during immunotherapy that modulate IgE synthesis. J Allergy Clin Immunol 1987; 79: 591–598
- Haida M, Okudaria H, Ogita T. Allergens of the house dust mite Dermatophagoids farinae– immunochemical studies of four allergenic fractions. J Allergy Clin Immunol 1985; 75: 686–692
- Gaffney E W, Chu C W, Lingenfelter S E, Lisa P J, Koch G A. Enzyme-linked immunoassay with monoclonal antibody for human interleukin-1 beta. Bio Techn 1987; 5: 652–657
- Noon L. Prophylactic inoculation against hay fever. Lancet 1911; 1: 1572–1573
- Warner J O, Price J F, Soothill J F, Hey E N. Controlled trial of hyposensitization to Dermatophagoids pteronyssinus in children with asthma. Lancet 1978; 2: 912–915
- Rocklin R E, Sheffer A L, Greeineder D K, Melmon K L. Generation of antigen-specific suppressor cells during allergy desensitization. N Engl J Med 1980; 302: 1213–1219
- Morley J, Smith D. Lung inflammation, its significance for asthma therapy. Agent Action 1989; 26: 31–39
- Lozewicz S, Gomez E, Ferguson H, Davies R J. Inflammatory cells in the airways in mild asthma. Br Med J 1988; 297: 1515–1516
- Beutler B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 1986; 320: 584–588
- Dinarello C A. An update on human interleukin-1: From molecular biology to clinical relevance. J Clin Immunol 1985; 5: 287–296
- Zucali J R, Elfenbein G J, Barth K C, Dinarello C A. Effects of human interleukin 1 and human tumor necrosis factor on human T lymphocyte colony formation. J Clin Invest 1987; 80: 772–777
- Moldawer L L, Gelin J, Schersten T, Lundholm K G. Circulating interleukin 1 and tumor necrosis factor during inflammation. Am J Physiol 1987; 253: R922–R928
- Dessaint J P, Capron A. Fc receptor for IgE on mononuclear phagocytes and IgE-dependent macrophage activation. Fed Proc 1982; 41: 966–969
- Joseph M., Tonnel A B, Torpier G, Capron A, Arnoux B, Benvenisite J. Involvement of IgE in the secretory processes of alveolar macrophages from asthmatic patients. J Clin Invest 1983; 71: 221–230
- Pujio J L, Cosso B, Daures J P, Clot J, Michel F B, Godard P. Interleukin-1 release by alveolar macrophages in asthmatic patients and healthy subjects. Int Arch Allergy Appl Immunol 1990; 92: 207–210
- Monick M, Glazier J, Hunninghake G W. Human alveolar macrophages suppress interleukin-1 activity via the secretion of prostaglandin. E2. Am Rev Respir Dis 1987; 135: 12–11
- Hsieh K H, Leu K H. Defective monokine production and decreased responsiveness of polymorphonuclear leukocytes to recombinant interleukin-1 in asthmatic patients. J Clin Immunol 1987; 7: 203–209
- Beutler B, Cerami A. Cachectin: More than a tumor necrosis factor. N Engl J Med 1987; 316: 379–385
- Nawroth P, Bank I, Handley D, Cassimeris J, Chess L, Stern D. Tumor necrosis factor&achectin interacts with endothelial cell receptor to induce release of interleukin-1. J Exp Med 1986; 163: 1363–1375
- Steffen M, Abbound M, Potter G K, Yung Y P, Moore M AS. Presenoe of tumor necrosis factor or a related factor in human basophil/mast cells. Immunology 1989; 66: 445–450
- Haak-Frendscho M, Dinarello C, Kaplan A P. Recombinant human interleukin-1 beta causes histamine release from human basophils. J Allergy Clin Immunol 1988; 82: 218–223
- Hsieh K H. Altered interleukin-2 (IL-2) production and responsiveness after hyposensitization to house dust. J Allergy Clin Immunol 1985; 76: 188–194
- Rak S, Hakansson L, Venge P. Eosinophil chemotac-tic activity in allergic patients in the birch pollen season: The effect of immunotherapy. Int Arch Allergy Appl Immunol 1987; 82: 349–350
- McHugh S M, Ewan P E. Reduction of increased serum neutrophil chemotactic activity following effective hyposensitization in house dust mite allergy. Clin Exp Allergy 1989; 19: 327–334
- Wang J Y, Hsieh K H. The effect of immunotherapy on the in vitro production of histamine, prostaglandin E2 and leukotriene C4 in asthmatic children. Asian Pac J Allergy Clin Immunol 1989; 7: 119–124
- Kelly C, Ward C, Stenton C S, Bird G, Hendrick D J, Walters E H. Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airway responsiveness. Thorax 1988; 43: 684–692